New combo therapy shows promise for older leukemia patients
NCT ID NCT03480438
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 33 times
Summary
This study tested a new treatment plan for adults aged 55-75 with a specific type of leukemia (B-precursor ALL). The approach uses a reduced dose of chemotherapy followed by a targeted drug called blinatumomab. The goal was to achieve remission while reducing harsh side effects. 52 participants were enrolled, and the study measured how many achieved complete remission and how long they lived.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-PRECURSOR ALL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Campus Benjamin Franklin
Berlin, Germany
-
Evangelisches Krankenhaus Essen-Werden
Essen, Germany
-
Evangelisches Krankenhaus Hamm
Hamm, Germany
-
Gemeinschaftsklinikum Mittelrhein
Koblenz, Germany
-
Helios Klinikum Wuppertal
Wuppertal, Germany
-
Klinikum Bremen Mitte
Bremen, Germany
-
Klinikum Großhadern
München, Germany
-
Klinikum Oldenburg
Oldenburg, Germany
-
Klinikum rechts der Isar der TU München
München, Germany
-
Städtisches Klinikum Braunschweig
Braunschweig, Germany
-
Städtisches Klinikum Karlsruhe
Karlsruhe, Germany
-
Uniklinik Hamburg Eppendorf
Hamburg, Germany
-
Uniklinik RWTH Aachen
Aachen, Germany
-
Uniklinik Würzburg
Würzburg, Germany
-
University Hospital of Frankfurt (Main)
Frankfurt am Main, Hesse, 60590, Germany
-
Universitätsklinik Tübingen
Tübingen, Germany
-
Universitätsklinikum Halle
Halle, Germany
-
Universitätsklinikum Leipzig
Leipzig, Germany
-
Universitätsklinikum Schleswig-Holstein
Kiel, Germany
-
Universitätsklinikum Ulm
Ulm, Germany
-
Vivantes Klinikum Neukölln
Berlin, Germany
Conditions
Explore the condition pages connected to this study.